The anticipation surrounding dose optimization data for Pfizer (NYSE:PFE)'s obesity treatment, danuglipron, was also mentioned as a point of interest for the first quarter. However, the analyst ...
Goldman Sachs adjusted its price target on shares of AMD (NASDAQ:AMD), bringing it down to $125.00 from the previous $129.00 while reaffirming a Neutral rating on the stock. The adjustment follows AMD ...
The Goldman Sachs Group Issues Positive Forecast for Piper Sandler Companies (NYSE:PIPR) Stock Price
Piper Sandler Companies (NYSE:PIPR – Free Report) had its price objective upped by The Goldman Sachs Group from $298.00 to $330.00 in a report released on Monday,Benzinga reports. The Goldman Sachs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results